258 related articles for article (PubMed ID: 35997979)
1. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
Arzika AM; Mindo-Panusis D; Abdou A; Kadri B; Nassirou B; Maliki R; Alsoudi AF; Zhang T; Cotter SY; Lebas E; O'Brien KS; Callahan EK; Bailey RL; West SK; Goodhew EB; Martin DL; Arnold BF; Porco TC; Lietman TM; Keenan JD;
JAMA Netw Open; 2022 Aug; 5(8):e2228244. PubMed ID: 35997979
[TBL] [Abstract][Full Text] [Related]
2. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
3. Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial.
Arzika AM; Maliki R; Ali MM; Alio MK; Abdou A; Cotter SY; Varnado NE; Lebas E; Cook C; Oldenburg CE; O'Brien KS; Callahan EK; Bailey RL; West SK; Porco TC; Lietman TM; Keenan JD;
JAMA Netw Open; 2021 Dec; 4(12):e2139351. PubMed ID: 34967883
[TBL] [Abstract][Full Text] [Related]
4. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD;
PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871
[TBL] [Abstract][Full Text] [Related]
5. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger.
Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Oldenburg CE
Ophthalmic Epidemiol; 2019 Aug; 26(4):231-237. PubMed ID: 30957594
[No Abstract] [Full Text] [Related]
6. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
[TBL] [Abstract][Full Text] [Related]
7. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II).
Mahmud H; Haile BA; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Liu Z; Callahan EK; Cotter SY; Varnado NE; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Clin Infect Dis; 2023 Aug; 77(3):388-395. PubMed ID: 37021692
[TBL] [Abstract][Full Text] [Related]
8. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
[TBL] [Abstract][Full Text] [Related]
9. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
[TBL] [Abstract][Full Text] [Related]
10. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
[TBL] [Abstract][Full Text] [Related]
11. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for ocular chlamydia after three mass azithromycin distributions.
Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM
Am J Trop Med Hyg; 2018 Feb; 98(2):389-395. PubMed ID: 29260659
[TBL] [Abstract][Full Text] [Related]
14. Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
Keenan JD; Gebresillasie S; Stoller NE; Haile BA; Tadesse Z; Cotter SY; Ray KJ; Aiemjoy K; Porco TC; Callahan EK; Emerson PM; Lietman TM
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007442. PubMed ID: 31166952
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma.
Amza A; Kadri B; Nassirou B; Arzika AM; Austin A; Nyatigo F; Lebas E; Arnold BF; Lietman TM; Oldenburg CE
BMC Ophthalmol; 2021 Jan; 21(1):15. PubMed ID: 33407263
[TBL] [Abstract][Full Text] [Related]
16. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
[TBL] [Abstract][Full Text] [Related]
17. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
[TBL] [Abstract][Full Text] [Related]
18. Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial.
Aragie S; Wittberg DM; Tadesse W; Dagnew A; Hailu D; Chernet A; Melo JS; Aiemjoy K; Haile M; Zeru T; Tadesse Z; Gwyn S; Martin DL; Arnold BF; Freeman MC; Nash SD; Callahan EK; Porco TC; Lietman TM; Keenan JD
Lancet Glob Health; 2022 Jan; 10(1):e87-e95. PubMed ID: 34919861
[TBL] [Abstract][Full Text] [Related]
19. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.
Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM; Oldenburg CE
Br J Ophthalmol; 2018 May; 102(5):680-686. PubMed ID: 28893761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
